Data / Form D filings / Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Ltd.: Form D filing
Voyageur Pharmaceuticals Ltd., a company in Calgary, Alberta, Canada, filed a Form D with the SEC in 2026. The latest, on August 10, 2026, reports $316,002 sold of a $4.8 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- #7-1700 VARSITY ESTATES DRIVE N.W., Calgary, Alberta, Canada, T3B 2
- Phone
- (877) 398-6866
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Alberta, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2147653
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | New notice | $4,759,409 | $316,002 | $4,443,407 | 2 | Jun 5, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brent Willis | Executive Officer, Director | |
| Albert Deslauriers | Executive Officer | |
| Willis Bradley | Executive Officer, Director | |
| Eugene Fritzel | Director | |
| Eric Pommer | Director | |
| Kevin McBeth | Director | |
| Beth Shaw | Director | |
| Christopher Van Buren | Director | |
| Jeffrey Kraws | Executive Officer | |
| Virginia Alling | Director | |
| Ethan Mohan | Director |
Every Form D from the week of Aug 10, 2026 · All recent Other filings
Read from SEC EDGAR. Amount sold is what Voyageur Pharmaceuticals Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.